Home > Riviste > Minerva Pediatrics > Fascicoli precedenti > Articles online first > Minerva Pediatrics 2021 Apr 15

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Pediatrics 2021 Apr 15

DOI: 10.23736/S2724-5276.21.06173-9

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

The impact of antimicrobial use on potential major drug-drug interactions in the pediatric intensive care unit patients at University Hospital, Turkey

Aslınur ALBAYRAK 1 , Emine AKKUZU 2, Bensu KARAHALIL 3

1 Department of Clinical Pharmacy, Faculty of Pharmacy, Gazi University, Ankara, Turkey; 2 Department of Pediatric İntensive Care, Medical Faculty, Gazi University, Ankara, Turkey; 3 Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey


PDF


BACKGROUND: Antimicrobials, especially antibiotics, are among the most widely used drugs in the pediatric intensive care unit. Pediatrics patients in intensive care unit are exposed to potential drug-drug interactions (PDDIs) and suffered from their adverse and side effects. The aim of this study is to evaluate the impact of antimicrobial use on PDDIs, as well as to examine the rate and the risk factors PDDIs, furthermore the management of PDDIs.
METHODS: The present retrospective cohort study included 179 patients under 18 years of age who were hospitalized in Pediatric Intensive Care Unit in Turkey. Drug interactions were evaluated using the Lexicomp® drug interaction tool which provides evidence-based drug information.
RESULTS: Our study results showed that the frequency of the use of antimicrobial drugs (antibiotic, antifungal, antiviral) was found to be statistically significantly higher (p<0.05) in the group with PDDIs compared to the group without PDDIs. Especially, the use of carbapenem, cephalosporin among the antibiotic groups significantly increased the frequency of PDDIs (p<0.05). While the probability PDDIs statistically significantly increased 3.73 times (OR (Odds Ratio) =3.73; 95% CI= 1.47-9.50) in patients who used a single antibiotic compared to patients who did not use antibiotics (p=0.006), the probability of the occurrence of PDDIs by using more than one antibiotic was statistically significantly 8.5 times (95% CI =3.30-21.89) (p <0.001).
CONCLUSIONS: Our study results showed that the use of antimicrobial drugs (antibiotic, antifungal, antiviral) was found to be statistically significantly higher (p<0.05) in the group with PDDIs.


KEY WORDS: Pediatric Intensive Care Units; Drug interactions; Polypharmacy; Antimicrobial agents

inizio pagina